November 18, 2026
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

WHO Condemns US-Funded Hepatitis B Vaccine Trial in Guinea-Bissau as “Unethical”

February 16, 2026

The World Health Organization (WHO) has criticized a US-funded hepatitis B vaccine trial in Guinea-Bissau, calling it "unethical" for proposing to delay life-saving vaccination for thousands of newborns.

The study, led by Danish researchers and funded by the US Health Department, aimed to give one group of babies the hepatitis B vaccine at birth while postponing vaccination for another group until six weeks old. The WHO said this approach exposed infants to “potentially irreversible harm,” given that the birth-dose vaccine is a proven public health intervention with decades of safe use in more than 115 countries.

“Hepatitis B vaccination at birth prevents mother-to-child transmission in 70–95% of cases,” the WHO said. Infection at birth is the most common route to lifelong infection, with 90% of infected newborns becoming chronic carriers.

Guinea-Bissau currently administers the vaccine at six weeks, but authorities plan to roll out the birth-dose nationwide by 2028, in line with global standards. The WHO stressed that the trial could have accelerated this rollout but criticized the study’s scientific justification, ethical safeguards, and alignment with established research standards.

The trial, which was set to involve 14,000 newborns, was suspended last month after public outrage. Critics questioned why babies in Africa were being used for a study that would withhold a proven life-saving intervention.

The US health department overseeing the study is headed by Robert F. Kennedy Jr., who has previously raised doubts about vaccines despite publicly stating that he and his children have been vaccinated. Two months ago, a panel appointed by Kennedy voted to stop recommending hepatitis B vaccination for all US newborns, raising further ethical concerns.

The WHO reiterated that withholding a proven vaccine in a clinical trial is only acceptable when no effective treatment exists. For hepatitis B, the birth-dose vaccine is a critical, life-saving measure.

Xi and Trump Share Surprise Embrace as US President Arrives in China

5 hours ago

Uganda Airlines Launches Daily Kigali Flights, Expands Network to 18 Destinations

6 hours ago

Museveni, Dangote Discuss Oil Refining, Fertiliser Production and Mining Investments

7 hours ago

Xi, Putin Discuss Global Security and Multipolar World Ahead of Trump Talks

8 hours ago

UK MPs Urge Government to Block UAE’s Lana Nusseibeh from UN Secretary-General Race Over Sudan War

15 hours ago

Uganda Airlines Launches Daily Kigali Flights, Expands Network to 18 Destinations

Museveni, Dangote Discuss Oil Refining, Fertiliser Production and Mining Investments

Xi, Putin Discuss Global Security and Multipolar World Ahead of Trump Talks

UK MPs Urge Government to Block UAE’s Lana Nusseibeh from UN Secretary-General Race Over Sudan War

Somalia President Accuses UAE of Interference, Calls for National Dialogue

Uganda’s NRM, China’s CPC Deepen Party-to-Party Cooperation in Institutional Development

FBI Warns Businesses Worldwide of AI Tool Enabling Cyberattacks in Under Three Hours

21 hours ago
Mike Todd Declared Apostle After Four-Hour Ceremony, Reigniting Debate Over Modern-Day Apostles

21 hours ago
Somalia President Accuses UAE of Interference, Calls for National Dialogue

22 hours ago
NVIDIA Founder Jensen Huang Apologises, Says He Would Be Honoured to Return as CEO

22 hours ago
Uganda’s NRM, China’s CPC Deepen Party-to-Party Cooperation in Institutional Development

22 hours ago
Mohammed Hamid and the AYA Group: The Ambitions, Risks and Realities of Indigenous Ugandan Investment

1 day ago
UPDF Seeks Shs1.9 Trillion for 100% Salary Increase for Military Personnel

1 day ago
Uganda Steps Up Border Security Through Modern Surveillance, Intelligence Coordination

1 day ago
International Crimes Division Resumes Trial of Former ADF Commander Jamil Mukulu

1 day ago
Pope Leo XIV Hit in Face by Rosary Thrown From Crowd During Peru Visit

1 day ago
Major US Banks Hit by Widespread Service Disruptions as Customers Report Account Access Problems

2 days ago
IOM Sets Conditions for Support to EU-Rwanda Migrant Return Hub

2 days ago

‘Let Us Move Forward’: Namuganza Speaks After Winning Election Court Battle

4 days ago

New Israeli Leadership Bid: Eisenkot Rules Out Using Security for Political Gain

5 days ago

Todwong, Tanzania’s Migiro Elected to African Political Parties Leadership in Addis Ababa

2 weeks ago

PLU Boss Fadil Meets Kayanja, Sserwada, Grace Lubega in New ‘Patriotic League of National Religious Leaders’

2 weeks ago

UG Diplomat is an independent digital news and media platform dedicated to comprehensive coverage of national politics, regional diplomacy, international relations, geopolitics, defense, and business. Published under Currentarc Media Ltd, we provide authoritative analysis, breaking news, and in-depth reporting on the diplomatic and economic developments shaping East Africa and the global arena.

COMPANY

Contact Us

Privacy Policy

Terms and Conditions

CONTACT INFORMATION

info@ugdiplomat.com

+256774552385

Copyright © 2026 UG Diplomat -Product of CURRENTARC MEDIA